Mesoblast made changes to the assay, which the told the FDA would apply to new product being produced.
This implies the curent on the shelf product, has not been subjec to those changes. FDA probably need proof now shelf product is conformal with trial product.
Mesoblast made changes to the assay, which the told the FDA...
-
- There are more pages in this discussion • 2,414 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.020(2.02%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.01 | 94.3¢ | $4.182M | 4.327M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 125882 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 91873 | 11 |
View Market Depth
| Last trade - 14.03pm 01/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |